Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Lorenzo Trippa, Ph.D.

Concepts (276)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Research Design30202562103.550 Why?
Bayes Theorem21202423532.850 Why?
Glioblastoma17202334612.540 Why?
Clinical Trials as Topic19202580481.690 Why?
Information Dissemination5202411421.490 Why?
Clinical Trials, Phase I as Topic220243291.460 Why?
Randomized Controlled Trials as Topic192025103931.360 Why?
Clinical Trials, Phase II as Topic420226381.080 Why?
Probability5202324760.900 Why?
Brain Neoplasms13202391080.880 Why?
Medical Futility220221360.850 Why?
Data Interpretation, Statistical6201826980.850 Why?
Maximum Tolerated Dose220248960.810 Why?
Models, Statistical8202450980.790 Why?
Random Allocation4202323940.730 Why?
Computer Simulation14202562600.720 Why?
Controlled Clinical Trials as Topic120211870.710 Why?
Biometry220145710.660 Why?
Drugs, Investigational120212110.630 Why?
Medical Oncology4202323410.600 Why?
Informed Consent1202410100.580 Why?
Antineoplastic Combined Chemotherapy Protocols172025118720.570 Why?
Carnitine120182530.570 Why?
Kaplan-Meier Estimate7202165130.540 Why?
Benchmarking1202310560.540 Why?
Inheritance Patterns120183440.520 Why?
Antineoplastic Agents52024136500.510 Why?
Algorithms122024140980.500 Why?
Tuberculosis, Multidrug-Resistant320219410.480 Why?
Multiple Myeloma10202551860.480 Why?
Antitubercular Agents4202113800.480 Why?
Neoplasms92025223500.470 Why?
Immunotherapy4202247450.450 Why?
Survival Analysis62021100920.440 Why?
Neurology120217850.430 Why?
Breast Neoplasms152021211780.430 Why?
Shock, Septic120187720.390 Why?
Humans9320257670400.390 Why?
Proportional Hazards Models62021125360.380 Why?
Waldenstrom Macroglobulinemia4202210760.370 Why?
Electronic Health Records3202348810.350 Why?
Pedigree1201845390.350 Why?
Monoclonal Gammopathy of Undetermined Significance220231760.350 Why?
Computational Biology3202035670.330 Why?
Head and Neck Neoplasms2202029300.310 Why?
Receptor, erbB-27202125990.300 Why?
Ovarian Neoplasms3202149030.280 Why?
Endpoint Determination520175920.280 Why?
Alleles1201868930.280 Why?
Paclitaxel4202117280.270 Why?
Disease-Free Survival7202168440.260 Why?
Decision Making4202339510.250 Why?
Sepsis1201826050.230 Why?
Receptors, CXCR4220197290.230 Why?
Organophosphorus Compounds120242090.210 Why?
Boron Compounds120251950.210 Why?
Software2201444720.210 Why?
Prospective Studies82022548860.200 Why?
Clinical Trials, Phase III as Topic220198780.190 Why?
Glycine120256700.190 Why?
Dexamethasone3202519630.180 Why?
Neurofibromatosis 2120243870.180 Why?
Gene Expression Profiling3202095320.170 Why?
Filgrastim120201310.170 Why?
Camptothecin120235990.170 Why?
Hematopoiesis3202020560.170 Why?
Treatment Outcome142025652950.160 Why?
Ketones120201830.160 Why?
Furans120201990.160 Why?
Paraproteinemias120222510.160 Why?
Oxazoles220201980.160 Why?
DNA Mismatch Repair120224310.160 Why?
Uncertainty120247650.160 Why?
Inappropriate Prescribing120212120.150 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis120223880.150 Why?
Neoadjuvant Therapy4202329020.140 Why?
Sample Size220178450.140 Why?
Anilides120194130.130 Why?
Respiratory Tract Diseases120227440.130 Why?
Antineoplastic Agents, Alkylating120206140.130 Why?
Factor Analysis, Statistical1201910020.130 Why?
Neoplasm Recurrence, Local4202394100.130 Why?
Models, Genetic2201834450.130 Why?
Female3420253966600.130 Why?
Immunoconjugates120239750.130 Why?
Estrogen Receptor alpha120205810.130 Why?
Nitroimidazoles120161180.120 Why?
Hematopoietic Stem Cell Transplantation4202257160.120 Why?
Patient Care120216280.120 Why?
Voltage-Sensitive Dye Imaging12014300.120 Why?
Neoplasm, Residual1202010120.120 Why?
Numerical Analysis, Computer-Assisted120141200.120 Why?
Polyethylene Glycols1202011880.110 Why?
Cyclophosphamide1202022270.110 Why?
Data Collection1202333210.110 Why?
Doxorubicin1202022290.110 Why?
BRCA2 Protein120188020.110 Why?
Pharmaceutical Preparations1202110850.110 Why?
Salvage Therapy1201912710.100 Why?
Mutation62020302110.100 Why?
Carcinoma, Ductal, Breast1202010970.100 Why?
Embryo, Mammalian2201616760.100 Why?
Likelihood Functions120159960.100 Why?
Rectal Neoplasms1202111830.100 Why?
Genes, Neoplasm120143690.100 Why?
Pyrimidines1202430440.100 Why?
BRCA1 Protein1201811550.090 Why?
Reproducibility of Results52019201690.090 Why?
Models, Biological2202094640.090 Why?
Molecular Sequence Annotation120145260.090 Why?
High-Throughput Screening Assays120179400.090 Why?
Survival Rate42020128230.090 Why?
Disease Progression62025136460.090 Why?
Pyridines2202028900.090 Why?
Transplantation, Autologous3202221180.090 Why?
Antibodies, Viral1202132120.090 Why?
Markov Chains120149760.090 Why?
Particulate Matter1202226210.080 Why?
Immunoglobulin G1202145600.080 Why?
Epidemiologic Methods1201413260.080 Why?
Prognosis72020299630.080 Why?
Risk4202296060.080 Why?
Patient Participation1201814440.080 Why?
Drug Discovery1201710680.080 Why?
Oligonucleotide Array Sequence Analysis2201437970.080 Why?
Decision Support Techniques1201920060.080 Why?
Patient Selection1202142560.080 Why?
Aged1820251713190.080 Why?
Point Mutation1201415910.080 Why?
Life Expectancy1201512480.080 Why?
Monte Carlo Method1201412500.080 Why?
Receptors, Estrogen3202022520.070 Why?
Male1820253642030.070 Why?
High-Throughput Nucleotide Sequencing1202036670.070 Why?
Middle Aged1820252232330.070 Why?
Papillomavirus Infections1201916390.070 Why?
Neoplasm Proteins1201935990.070 Why?
Asymptomatic Diseases220215880.070 Why?
Cell Lineage1201625750.070 Why?
Drug Administration Schedule3202048550.070 Why?
Genomics2202059240.070 Why?
Environmental Exposure1202245460.070 Why?
Genotype22018130350.070 Why?
DNA Copy Number Variations1201520470.060 Why?
Immunoglobulin M2202215270.060 Why?
Databases, Factual1202180680.060 Why?
Adult1620252233170.060 Why?
Receptors, Progesterone2202011590.060 Why?
Tuberculosis1201820110.060 Why?
Cross-Over Studies2202221050.060 Why?
Palliative Care1202036410.060 Why?
Recurrence2201985040.060 Why?
Single-Cell Analysis1201625380.060 Why?
Aged, 80 and over82025595480.060 Why?
Drug Resistance, Neoplasm1201953320.060 Why?
Genetic Association Studies1201427440.060 Why?
Glioma1201935020.060 Why?
Hearing Disorders120241260.060 Why?
Stochastic Processes220153590.060 Why?
Combined Modality Therapy3202085350.050 Why?
Neoplasm Metastasis1201448920.050 Why?
Gene Expression Regulation, Developmental1201436100.050 Why?
Administration, Oral2202440260.050 Why?
Sensitivity and Specificity22015146720.050 Why?
Quinazolines2202013690.050 Why?
Time Factors22021401540.050 Why?
Hippocampus1201437770.050 Why?
Chemotherapy, Adjuvant2202035520.050 Why?
Ki-67 Antigen120236300.050 Why?
B-Lymphocytes1201447870.050 Why?
Epigenesis, Genetic1201438280.050 Why?
Immunologic Tests120211010.050 Why?
MicroRNAs1201737920.050 Why?
Pandemics1202187360.040 Why?
Premedication120212450.040 Why?
Gene Expression Regulation, Neoplastic1201786280.040 Why?
Neurofibromatoses120243030.040 Why?
Risk Factors42022748860.040 Why?
Artificial Intelligence1201426660.040 Why?
Neoplasm Staging32021112170.040 Why?
Models, Immunological120215160.040 Why?
Rifampin120213500.040 Why?
Diagnostic Imaging1201335300.040 Why?
Bone Marrow2201929260.040 Why?
Neurilemmoma120245220.040 Why?
Sequence Analysis, RNA2201720400.040 Why?
Benzylamines120192510.040 Why?
Heterocyclic Compounds120192450.040 Why?
Melanoma1201757020.040 Why?
Tumor Burden1202419030.040 Why?
Prostatic Neoplasms12021110970.040 Why?
beta 2-Microglobulin120193300.040 Why?
Dioxygenases120203530.040 Why?
Follow-Up Studies42020393170.040 Why?
Tumor Suppressor Protein p532202029520.040 Why?
Creatinine1202319160.030 Why?
Cell Differentiation12014116570.030 Why?
Standard of Care120215690.030 Why?
Young Adult52024599800.030 Why?
Immunocompromised Host120218620.030 Why?
Cardiovascular Diseases12022156450.030 Why?
Administration, Cutaneous120187150.030 Why?
Purines120196140.030 Why?
Gene Dosage1202012110.030 Why?
Antigens, Neoplasm1202319970.030 Why?
Comparative Effectiveness Research120217130.030 Why?
Heterozygote1202227940.030 Why?
Hematologic Diseases120194980.030 Why?
Genome-Wide Association Study12015127900.030 Why?
Melphalan120174210.030 Why?
Aminopyridines120195780.030 Why?
Infusions, Intravenous1202022270.030 Why?
Karyotyping1201711760.030 Why?
Myeloid Differentiation Factor 88120195820.030 Why?
Mass Spectrometry1202222010.030 Why?
Retrospective Studies52023816590.030 Why?
Databases as Topic120164720.030 Why?
Cisplatin1202016560.030 Why?
Risk Assessment32021242990.030 Why?
Germ-Line Mutation1202218850.030 Why?
Comparative Genomic Hybridization120154740.030 Why?
Infection Control120219840.030 Why?
Immune System120197990.030 Why?
Immunologic Factors1202215920.030 Why?
Papillomaviridae1201911390.030 Why?
Cohort Studies32022417180.030 Why?
Mice, Inbred NOD1201718370.030 Why?
Exosomes120174170.020 Why?
Mice, SCID1201726260.020 Why?
Neoplastic Stem Cells1201913490.020 Why?
Gastrointestinal Diseases1201912050.020 Why?
Breast1202019720.020 Why?
Mice, Knockout22017144760.020 Why?
Predictive Value of Tests22019154240.020 Why?
Clinical Protocols1201514430.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201745720.020 Why?
PTEN Phosphohydrolase1201511190.020 Why?
Indoles1201718360.020 Why?
Xenograft Model Antitumor Assays1201736080.020 Why?
Isocitrate Dehydrogenase120159510.020 Why?
Mice42017819120.020 Why?
Air Pollution1202223780.020 Why?
Air Pollutants1202229200.020 Why?
Proto-Oncogene Proteins1202045220.020 Why?
Protein Kinase Inhibitors1202456930.020 Why?
Dose-Response Relationship, Drug12019107480.020 Why?
Sulfonamides1201719820.020 Why?
Models, Theoretical1201935610.020 Why?
Radiology1202121060.020 Why?
Health Personnel1202133870.020 Why?
Tumor Microenvironment1201939440.020 Why?
Gene Expression1201975870.020 Why?
Boston1201993600.020 Why?
Feasibility Studies1201753110.020 Why?
Homeodomain Proteins1201424290.020 Why?
Biopsy1201767770.020 Why?
Prevalence12022158510.010 Why?
Skin Neoplasms1202458590.010 Why?
Evidence-Based Medicine1201637000.010 Why?
Phenotype12022167180.010 Why?
Medicare1202268130.010 Why?
Animals420171689650.010 Why?
Apoptosis1201995130.010 Why?
DNA-Binding Proteins1202096120.010 Why?
Quality of Life12024134850.010 Why?
Child22024807710.010 Why?
Hospitalization12022108150.010 Why?
Adolescent22024890460.010 Why?
United States22022729710.010 Why?
Cell Line, Tumor12017170970.010 Why?
Case-Control Studies12017222540.010 Why?
Image Processing, Computer-Assisted1201489400.010 Why?
Magnetic Resonance Imaging12024365820.010 Why?
Signal Transduction12017236210.010 Why?
Infant12015364850.010 Why?
Child, Preschool12015426060.010 Why?
Trippa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (276)
Explore
_
Co-Authors (152)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.